Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1880 1
1886 1
1911 3
1914 1
1915 3
1916 1
1917 5
1922 1
1928 1
1930 1
1935 1
1936 1
1940 1
1942 1
1943 2
1945 1
1947 1
1948 4
1949 1
1950 1
1951 2
1952 3
1953 5
1954 5
1955 5
1956 6
1957 4
1958 8
1959 4
1960 10
1961 9
1962 12
1963 12
1964 11
1965 13
1966 12
1967 24
1968 27
1969 15
1970 29
1971 33
1972 30
1973 28
1974 33
1975 21
1976 23
1977 24
1978 28
1979 43
1980 41
1981 50
1982 51
1983 57
1984 55
1985 39
1986 47
1987 41
1988 34
1989 40
1990 52
1991 54
1992 48
1993 42
1994 49
1995 29
1996 69
1997 40
1998 47
1999 53
2000 43
2001 44
2002 32
2003 31
2004 34
2005 40
2006 56
2007 47
2008 46
2009 50
2010 44
2011 53
2012 54
2013 69
2014 76
2015 72
2016 78
2017 76
2018 73
2019 75
2020 76
2021 89
2022 44
Text availability
Article attribute
Article type
Publication date

Search Results

2,604 results
Results by year
Filters applied: . Clear all
Page 1
Secondary Progressive Multiple Sclerosis: New Insights.
Cree BAC, Arnold DL, Chataway J, Chitnis T, Fox RJ, Pozo Ramajo A, Murphy N, Lassmann H. Cree BAC, et al. Among authors: fox rj. Neurology. 2021 Aug 24;97(8):378-388. doi: 10.1212/WNL.0000000000012323. Epub 2021 Jun 4. Neurology. 2021. PMID: 34088878 Free PMC article. Review.
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.
Kappos L, Bar-Or A, Cree BAC, Fox RJ, Giovannoni G, Gold R, Vermersch P, Arnold DL, Arnould S, Scherz T, Wolf C, Wallström E, Dahlke F; EXPAND Clinical Investigators. Kappos L, et al. Among authors: fox rj. Lancet. 2018 Mar 31;391(10127):1263-1273. doi: 10.1016/S0140-6736(18)30475-6. Epub 2018 Mar 23. Lancet. 2018. PMID: 29576505 Clinical Trial.
Cancer health disparities in racial/ethnic minorities in the United States.
Zavala VA, Bracci PM, Carethers JM, Carvajal-Carmona L, Coggins NB, Cruz-Correa MR, Davis M, de Smith AJ, Dutil J, Figueiredo JC, Fox R, Graves KD, Gomez SL, Llera A, Neuhausen SL, Newman L, Nguyen T, Palmer JR, Palmer NR, Pérez-Stable EJ, Piawah S, Rodriquez EJ, Sanabria-Salas MC, Schmit SL, Serrano-Gomez SJ, Stern MC, Weitzel J, Yang JJ, Zabaleta J, Ziv E, Fejerman L. Zavala VA, et al. Among authors: fox r. Br J Cancer. 2021 Jan;124(2):315-332. doi: 10.1038/s41416-020-01038-6. Epub 2020 Sep 9. Br J Cancer. 2021. PMID: 32901135 Free PMC article. Review.
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial.
Ramakrishnan S, Nicolau DV Jr, Langford B, Mahdi M, Jeffers H, Mwasuku C, Krassowska K, Fox R, Binnian I, Glover V, Bright S, Butler C, Cane JL, Halner A, Matthews PC, Donnelly LE, Simpson JL, Baker JR, Fadai NT, Peterson S, Bengtsson T, Barnes PJ, Russell REK, Bafadhel M. Ramakrishnan S, et al. Among authors: fox r. Lancet Respir Med. 2021 Jul;9(7):763-772. doi: 10.1016/S2213-2600(21)00160-0. Epub 2021 Apr 9. Lancet Respir Med. 2021. PMID: 33844996 Free PMC article. Clinical Trial.
Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study: A Randomized Clinical Trial.
Kappos L, Fox RJ, Burcklen M, Freedman MS, Havrdová EK, Hennessy B, Hohlfeld R, Lublin F, Montalban X, Pozzilli C, Scherz T, D'Ambrosio D, Linscheid P, Vaclavkova A, Pirozek-Lawniczek M, Kracker H, Sprenger T. Kappos L, et al. Among authors: fox rj. JAMA Neurol. 2021 May 1;78(5):558-567. doi: 10.1001/jamaneurol.2021.0405. JAMA Neurol. 2021. PMID: 33779698 Free PMC article. Clinical Trial.
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.
Primrose JN, Fox RP, Palmer DH, Malik HZ, Prasad R, Mirza D, Anthony A, Corrie P, Falk S, Finch-Jones M, Wasan H, Ross P, Wall L, Wadsley J, Evans JTR, Stocken D, Praseedom R, Ma YT, Davidson B, Neoptolemos JP, Iveson T, Raftery J, Zhu S, Cunningham D, Garden OJ, Stubbs C, Valle JW, Bridgewater J; BILCAP study group. Primrose JN, et al. Among authors: fox rp. Lancet Oncol. 2019 May;20(5):663-673. doi: 10.1016/S1470-2045(18)30915-X. Epub 2019 Mar 25. Lancet Oncol. 2019. PMID: 30922733 Free article. Clinical Trial.
Serum neurofilament light as a biomarker in progressive multiple sclerosis.
Kapoor R, Smith KE, Allegretta M, Arnold DL, Carroll W, Comabella M, Furlan R, Harp C, Kuhle J, Leppert D, Plavina T, Sellebjerg F, Sincock C, Teunissen CE, Topalli I, von Raison F, Walker E, Fox RJ. Kapoor R, et al. Among authors: fox rj. Neurology. 2020 Sep 8;95(10):436-444. doi: 10.1212/WNL.0000000000010346. Epub 2020 Jul 16. Neurology. 2020. PMID: 32675076 Free PMC article. Review.
Diagnosis of Progressive Multiple Sclerosis From the Imaging Perspective: A Review.
Filippi M, Preziosa P, Barkhof F, Chard DT, De Stefano N, Fox RJ, Gasperini C, Kappos L, Montalban X, Moraal B, Reich DS, Rovira À, Toosy AT, Traboulsee A, Weinshenker BG, Zeydan B, Banwell BL, Rocca MA. Filippi M, et al. Among authors: fox rj. JAMA Neurol. 2021 Mar 1;78(3):351-364. doi: 10.1001/jamaneurol.2020.4689. JAMA Neurol. 2021. PMID: 33315071 Review.
Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis.
Simpson-Yap S, De Brouwer E, Kalincik T, Rijke N, Hillert JA, Walton C, Edan G, Moreau Y, Spelman T, Geys L, Parciak T, Gautrais C, Lazovski N, Pirmani A, Ardeshirdavanai A, Forsberg L, Glaser A, McBurney R, Schmidt H, Bergmann AB, Braune S, Stahmann A, Middleton R, Salter A, Fox RJ, van der Walt A, Butzkueven H, Alroughani R, Ozakbas S, Rojas JI, van der Mei I, Nag N, Ivanov R, Sciascia do Olival G, Dias AE, Magyari M, Brum D, Mendes MF, Alonso RN, Nicholas RS, Bauer J, Chertcoff AS, Zabalza A, Arrambide G, Fidao A, Comi G, Peeters L. Simpson-Yap S, et al. Among authors: fox rj. Neurology. 2021 Nov 9;97(19):e1870-e1885. doi: 10.1212/WNL.0000000000012753. Epub 2021 Oct 5. Neurology. 2021. PMID: 34610987 Free PMC article.
2,604 results